文献速递结核与非结核分枝杆菌

潜伏性结核感染治疗中γ干扰素释放试验结果的动态变化

Dynamic changes of interferon gamma release assay results with latent tuberculosis infection treatment.
PubMed 文献 · Clin Microbiol Infect · 2020-02-13

该随机对照研究纳入910例接受8周每周一次利福喷汀联合异烟肼治疗者、890例接受6周每周两次利福喷汀联合异烟肼治疗者和818例未治疗对照,随访2年。结果发现三组QFT-GIT持续逆转率相似(19.0%、18.5%、20.7%,p=0.512),IFN-γ水平动态变化无统计学差异。结论认为QFT-GIT逆转或IFN-γ水平下降不能用于监测潜伏性结核感染治疗反应。

要点

  • QFT-GIT逆转率在治疗组与未治疗对照组间无显著差异(p=0.512)。
  • 治疗者中基线IFN-γ较高者结核发生率高于较低者(1.0% vs 0.2%,p=0.037)。
  • QFT-GIT逆转或IFN-γ下降不宜用于监测潜伏性结核感染治疗反应。

核心结论

  • QFT-GIT逆转或IFN-γ水平下降不应作为监测潜伏性结核感染治疗宿主反应的指标。

研究设计与样本

  • 随机对照研究,共纳入910例接受8周每周一次利福喷汀联合异烟肼治疗者(A组)、890例接受6周每周两次利福喷汀联合异烟肼治疗者(B组)和818例未治疗对照(C组),随访2年。

主要发现

  • QFT-GIT持续逆转率在A组为19.0%(173/910)、B组为18.5%(165/890)、C组为20.7%(169/818),三组间p=0.512。
  • 三组间IFN-γ水平的动态变化无统计学显著性差异。
  • 在治疗参与者中,基线IFN-γ水平较高者结核发生率(1.0%,9/896)高于基线水平较低者(0.2%,2/904),p=0.037。
  • 在未治疗对照中观察到类似趋势但无统计学显著性(1.8%(7/400)vs 0.5%(2/418),p=0.100)。
  • 将结核病例与非结核病例按基线IFN-γ水平匹配后,无论是否接受治疗,IFN-γ水平随时间的动态变化均无显著差异。

临床怎么用

  • 临床不应使用QFT-GIT逆转或IFN-γ水平下降来评估潜伏性结核感染治疗是否有效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Using QuantiFERON-TB Gold In-Tube (QFT-GIT) for monitoring tuberculosis (TB) and latent TB infection treatment effect is controversial. The present study aimed to evaluate the dynamic changes of interferon gamma (IFN-γ) levels along with latent TB infection treatment via a randomized controlled study. METHODS: A total of 910 participants treated with 8 weeks of once-weekly rifapentine plus isoniazid (group A), 890 treated with 6 weeks of twice-weekly rifapentine plus isoniazid (group B) and 818 untreated controls (group C) were followed for 2 years to track active TB development. QFT-GIT tests were repeated three times for all groups: before treatment (T0), at completion of treatment (T1) and 3 months after completion of treatment (T2). RESULTS: Similar rates of persistent QFT-GIT reversion were observed in groups A (19.0%, 173/910), B (18.5%, 165/890) and C (20.7%, 169/818) (p 0.512). The dynamic changes of IFN-γ levels were not statistically significant among the three groups. In treated participants, individuals with higher baseline IFN-γ levels showed increased TB occurrence (1.0%, 9/896) compared to those with lower baseline levels (0.2%, 2/904) (p 0.037). A similar but statistically insignificant trend was also observed in untreated controls (1.8% (7/400) vs. 0.5% (2/418), p 0.100). When TB cases were matched with non-TB cases on baseline IFN-γ levels, no significant differences were found with respect to the dynamic changes in IFN-γ levels with time, regardless of whether they received treatment. CONCLUSIONS: QFT-GIT reversion or decreased IFN-γ levels should not be used for monitoring host response to latent TB infection treatment.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Xin H, Cao X, Zhang H, et al. Dynamic changes of interferon gamma release assay results with latent tuberculosis infection treatment. Clin Microbiol Infect. 2020. PMID: 32062048. doi:10.1016/j.cmi.2020.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。